Home › Funds › DV EQUITIES, LLC › PHVS
DV EQUITIES, LLC position in PHVS
PHARVARIS N V · Health Care
DV EQUITIES, LLC reported holding 482,524 shares of PHVS (PHARVARIS N V) in its Q2 2026 13F filing — a position valued at US$16.7M, representing 2.42% of its reported portfolio and ranking #9 among its reported holdings. DV EQUITIES, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DV EQUITIES, LLC's PHVS position evolved
DV EQUITIES, LLC first disclosed a stake in PHVS in Q2 2026 at 482,524 shares (US$16.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 482.52K | $16.69M | New |
About PHVS and 13F data
PHVS (PHARVARIS N V) is a Health Care company. 49 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PHVS
- GENERAL ATLANTIC, L.P. 6.55M sh · $226.53M · Q2 2026
- Foresite Capital Management IV, LLC 4.78M sh · $165.24M · Q2 2026
- venBio Partners LLC 4.64M sh · $160.57M · Q2 2026
- EQT Fund Management S.a r.l. 3.42M sh · $118.42M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.38M sh · $116.74M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 2.68M sh · $92.52M · Q2 2026
- Commodore Capital LP 1.43M sh · $49.28M · Q2 2026
- Novo Holdings A/S 1.40M sh · $48.41M · Q2 2026
- Saturn V Capital Management LP 1.31M sh · $45.44M · Q2 2026
- TCG Crossover Management, LLC 1.01M sh · $34.86M · Q2 2026
- Sofinnova Investments, Inc. 881.30K sh · $30.48M · Q2 2026
- 5AM Venture Management, LLC 797.60K sh · $27.58M · Q2 2026
More on DV EQUITIES, LLC
FAQ
How long has DV EQUITIES, LLC held PHVS?
DV EQUITIES, LLC has disclosed PHVS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is DV EQUITIES, LLC's current position in PHVS?
As of Q2 2026, DV EQUITIES, LLC holds 482.52K shares of PHVS (PHARVARIS N V), valued at $16.69M, representing 2.42% of its reported portfolio and ranking #9.
Has DV EQUITIES, LLC been buying or selling PHVS?
In the latest 13F filing (Q2 2026), DV EQUITIES, LLC newly opened its position in PHVS.
Which other funds hold PHVS?
Other major institutional holders of PHVS include GENERAL ATLANTIC, L.P., Foresite Capital Management IV, LLC, venBio Partners LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.